Microcirculation as determined by iontophoresis in SLE-patients and controls

Lupus

Volumn 21, Issue 8, 2012, Pages 815-820

  Anania, C ^a   Norman, M ^b   Heimburger, M ^a   Gustafsson, T ^b   Jogestrand, T ^b   Hafstrom I ^a   Frostegard J ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

atherosclerosis; endothelial dysfunction; Systemic lupus erythematosus

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHLOROQUINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOCORTICOID; NITRIC OXIDE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; ASSAY; ATHEROSCLEROTIC PLAQUE; B SCAN; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; COMMON CAROTID ARTERY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMAGING SYSTEM; INTIMA; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; LASER DOPPLER FLUXMETRY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MICROCIRCULATION; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SKIN BLOOD FLOW; SKIN MANIFESTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; THICKNESS; TUNICA MEDIA; ULTRASOUND; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ADULT; ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; CAROTID STENOSIS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IONTOPHORESIS; LASERS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICROCIRCULATION; MIDDLE AGED; NEPHRITIS; RAYNAUD DISEASE; SKIN; STATISTICS, NONPARAMETRIC; VASODILATOR AGENTS;

EID: 84861815727     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312439117     Document Type: Article

References (30)

1. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med. 1976 ; 60: 221-225
2. Frostegard J. Atherosclerosis in patients with autoimmune disorders. Arterioscler Thromb Vasc Biol. 2005 ; 25 (9). 1776-1785
3. Anania C, Gustafsson T, Hua X, et al. Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus. Arthritis Res Ther. 2010 ; 12: R214 - R214
4. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003 ; 349: 2399-406
5. Charakida M, Masi S, Luscher TF, Kastelein JJ, Deanfield JE. Assessment of atherosclerosis: the role of flow-mediated dilatation. 31. Eur Heart J.: 2854-861
6. Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 1995 ; 26: 1235-1241
7. Gardner-Medwin JM, Taylor JY, Macdonald IA, Powell RJ. An investigation into variability in microvascular skin blood flow and the responses to transdermal delivery of acetylcholine at different sites in the forearm and hand. Br J Clin Pharmacol. 1997 ; 43: 391-397
8. Hu J, Norman M, Wallensteen M, Gennser G. Increased large arterial stiffness and impaired acetylcholine induced skin vasodilatation in women with previous gestational diabetes mellitus. Br J Obstet Gynaecol. 1998 ; 105: 1279-1287
9. Martin H, Hu J, Gennser G, Norman M. Impaired endothelial function and increased carotid stiffness in 9-year-old children with low birthweight. Circulation. 2000 ; 102: 2739-2744
10. Hansell J, Henareh L, Agewall S, Norman M. Non-invasive assessment of endothelial function-relation between vasodilatory responses in skin microcirculation and brachial artery. Clin Physiol Funct Imaging. 2004 ; 24: 317-322
11. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
12. Bengtsson C, Andersson SE, Edvinsson L, Edvinsson ML, Sturfelt G, Nived O. Effect of medication on microvascular vasodilatation in patients with systemic lupus erythematosus. Basic Clin Pharmacol Toxicol. 2010 ; 107: 919-924
13. de Leeuw K, Blaauw J, Smit A, Kallenberg C, Bijl M. Vascular responsiveness in the microcirculation of patients with systemic lupus erythematosus is not impaired. Lupus. 2008 ; 17: 1010-1017
14. van Eijk IC, Serne EH, Dijkmans BA, Smulders Y, Nurmohamed M. Microvascular function is preserved in newly diagnosed rheumatoid arthritis and low systemic inflammatory activity. Clin Rheumatol. 2011 ; 30: 1113-8
15. Morf S, Amann-Vesti B, Forster A, et al. Microcirculation abnormalities in patients with fibromyalgia-measured by capillary microscopy and laser fluxmetry. Arthritis Res Ther. 2005 ; 7: R209 - R216
16. van Eijk IC, Peters MJ, Serne EH, et al. Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor alpha blockade. Ann Rheum Dis. 2009 ; 68: 362-366
17. Gori T, Di Stolfo G, Sicuro S, et al. Correlation analysis between different parameters of conduit artery and microvascular vasodilation. Clin Hemorheol Microcirc. 2006 ; 35: 509-515
18. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004 ; 109 (23 Suppl 1). III27 - III32
19. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986 ; 315: 1046-1051
20. Berghoff M, Kathpal M, Kilo S, Hilz MJ, Freeman R. Vascular and neural mechanisms of ACh-mediated vasodilation in the forearm cutaneous microcirculation. J Appl Physiol. 2002 ; 92: 780-788
21. El-Magadmi M, Bodill H, Ahmad Y, et al. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation. 2004 ; 110: 399-404
22. Lima DS, Sato EI, Lima VC, Miranda F, Hatta FH. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol. 2002 ; 29: 292-297
23. Valdivielso P, Gomez-Doblas JJ, Macias M, et al. Lupus-associated endothelial dysfunction, disease activity and arteriosclerosis. Clin Exp Rheumatol. 2008 ; 26: 827-833
24. Kiss E, Soltesz P, Der H, et al. Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients. J Autoimmun. 2006 ; 27: 211-217
25. Cypiene A, Kovaite M, Venalis A, et al. Arterial wall dysfunction in systemic lupus erythematosus. Lupus. 2009 ; 18: 522-529
26. Aizer J, Karlson EW, Chibnik LB, et al. A controlled comparison of brachial artery flow mediated dilation (FMD) and digital pulse amplitude tonometry (PAT) in the assessment of endothelial function in systemic lupus erythematosus. Lupus. 2009 ; 18: 235-242
27. Nienhuis HL, de Leeuw K, Bijzet J, et al. Small artery elasticity is decreased in patients with systemic lupus erythematosus without increased intima media thickness. Arthritis Res Ther. 2010 ; 12: R181 - R181
28. Svenungsson E, Jensen-Urstad K, Heimburger M, et al. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation. 2001 ; 104: 1887-1893
29. Su J, Hua X, Concha H, Svenungsson E, Cederholm A, Frostegard J. Natural antibodies against phosphorylcholine as potential protective factors in SLE. Rheumatology (Oxford). 2008 ; 47: 1144-1150
30. Martin H, Lindblad B, Norman M. Endothelial function in newborn infants is related to folate levels and birth weight. Pediatrics. 2007 ; 119: 1152-1158